NCT03611244

Brief Summary

This study will be conducted without blind method. The portable seat device devised to maintain lumbar lordosis will be made within 1 year after the loss of ambulation in the participants with Duchenne muscular dystrophy with prospective design. In the control group, the presence of scoliosis will be calculated 5 years after the loss of ambulation in participants with Duchenne muscular dystrophy through analysis of retrospective medical records who had not been applied the portable seat device.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
98

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 25, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 2, 2018

Completed
5 days until next milestone

Study Start

First participant enrolled

August 7, 2018

Completed
6.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

September 18, 2018

Status Verified

September 1, 2018

Enrollment Period

6.3 years

First QC Date

July 25, 2018

Last Update Submit

September 15, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of scoliosis

    Frequency of scoliosis more than 10 degrees on spine x-ray on supine position

    5 years after loss of ambulation

Secondary Outcomes (1)

  • Incidence of scoliosis

    "Day 0", "Month 6" "Month 12" "Month 18" "Month 24" "Month 30" "Month 36" "Month 42" "Month 48" "Month 54" "Month 60"

Study Arms (2)

Experimental group

EXPERIMENTAL

When loss of ambulation was observed in patients with Duchenne muscular dystrophy, portable seat device devised to maintain lumbar lordosis were applied within 1 year, and then compliance with the the device were evaluated at 6-month intervals for 5 years.

Device: Portable seat device devised to maintain lumbar lordosis

Control group

NO INTERVENTION

Analysis of retrospective medical records who had not been applied portable seat device devised to maintain lumbar lordosis

Interventions

The posterior lumbar spine pads are used to maintain lumbar lordosis and fix it with the shoulder strap so that the hip does not slip forward (so that it does not become a sacral sitting posture). The seat is equipped with a 5 cm air filled villus cushion to relieve pressure on the ischial tuberosity when sitting for a long time. The portable seat device can be moved so that the DMD can sit on the device even when sitting in a wheelchair or a chair for home, school, or outdoors, so that the lumbar lordosis can be constantly maintained.

Experimental group

Eligibility Criteria

Age7 Years - 15 Years
Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patients with the diagnosis of Duchenne muscular dystrophy diagnosed by genetic study were included.
  • Within 1 year after loss of ambulation (Vignos scale 7 points or more)
  • Condition without scoliosis
  • Conditions that do not have physical (eg, cerebral palsy) and mental (eg, moderate or higher intellectual disability) comorbid conditions that will affect the use of postural seat device.

You may not qualify if:

  • Patients who do not agree to participate in this study
  • Patients not taking steroids
  • Patient with scoliosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Seoul National University

Seoul, 03080, South Korea

RECRUITING

Seoul National University Hospital

Seoul, South Korea

RECRUITING

MeSH Terms

Conditions

Muscular Dystrophy, Duchenne

Condition Hierarchy (Ancestors)

Muscular DystrophiesMuscular Disorders, AtrophicMuscular DiseasesMusculoskeletal DiseasesNeuromuscular DiseasesNervous System DiseasesGenetic Diseases, X-LinkedGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • You Gyoung Yi, M.D., MSc

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

You Gyoung Yi, M.D., MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

July 25, 2018

First Posted

August 2, 2018

Study Start

August 7, 2018

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

September 18, 2018

Record last verified: 2018-09

Data Sharing

IPD Sharing
Will not share

Locations